Literature DB >> 2472876

Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells.

C L Sommers1, D Walker-Jones, S E Heckford, P Worland, E Valverius, R Clark, F McCormick, M Stampfer, S Abularach, E P Gelmann.   

Abstract

To characterize differences in gene expression between hormone-dependent and hormone-independent mammary carcinoma, we cloned complementary DNAs of genes expressed in a hormone-independent breast carcinoma cell line that were not expressed in a hormone-dependent line. One clone, which was isolated in many copies, coded for the intermediate filament protein vimentin. A complementary DNA clone 1.8 kilobases long included the entire protein-coding region for vimentin. Vimentin was expressed by more than one-half of the hormone-independent breast carcinoma cell lines tested but not by the hormone-dependent cell lines. The cell lines which expressed vimentin expressed only low levels of cytokeratins. The correlation between vimentin expression and more advanced stages of mammary cell transformation was tested in a model system in which immortal, nontumorigenic human mammary epithelial cells or derivative lines transformed with v-ras-H or SV40 T-antigen were found not to express vimentin, whereas a derivative highly tumorigenic cell line transformed by both v-ras-H and T-antigen did express vimentin. Analysis of several other kinds of epithelial carcinoma cell lines showed only rare examples of vimentin expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2472876

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

1.  Mutated c-Ha-ras oncogene alters cytokeratin expression in the human breast epithelial cell line MCF-10A.

Authors:  T M Paine; G Fontanini; F Basolo; I Geronimo; J W Elliott; J Russo
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

Review 2.  Biomarkers for epithelial-mesenchymal transitions.

Authors:  Michael Zeisberg; Eric G Neilson
Journal:  J Clin Invest       Date:  2009-06-01       Impact factor: 14.808

3.  Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior.

Authors:  M J Hendrix; E A Seftor; R E Seftor; K T Trevor
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 4.  Role of intermediate filaments in migration, invasion and metastasis.

Authors:  M J Hendrix; E A Seftor; Y W Chu; K T Trevor; R E Seftor
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

Review 5.  Significance of talin in cancer progression and metastasis.

Authors:  Andreas Desiniotis; Natasha Kyprianou
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

6.  Molecular analysis of two mammary carcinoma cell lines at the transcriptional level as a model system for progression of breast cancer.

Authors:  S Schiemann; M Schwirzke; N Brünner; U H Weidle
Journal:  Clin Exp Metastasis       Date:  1998-02       Impact factor: 5.150

7.  Vimentin expression in benign and malignant breast epithelium.

Authors:  M Heatley; C Whiteside; P Maxwell; P Toner
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

8.  E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells.

Authors:  I Tamm; I Cardinale; T Kikuchi; J G Krueger
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

9.  Oncogene-induced basement membrane invasiveness in human mammary epithelial cells.

Authors:  E W Thompson; J Torri; M Sabol; C L Sommers; S Byers; E M Valverius; G R Martin; M E Lippman; M R Stampfer; R B Dickson
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

10.  In vitro culture and characterization of a mammary epithelial cell line from Chinese Holstein dairy cow.

Authors:  Han Hu; Jiaqi Wang; Dengpan Bu; Hongyang Wei; Linyun Zhou; Fadi Li; Juan J Loor
Journal:  PLoS One       Date:  2009-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.